Sydney Adventist Hospital 02 9487 9111


Sydney Adventist Hospital
« View pages

Clinical Specialties & Services

Gatrointestinal Cancer Clinical Trials

ASCENT

An Australian Translational Study to Evaluate the Prognostic Role of Inflammatory Markers in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab (Avastin™)

http://clinicaltrials.gov/ct2/show/NCT01588990


Challenge – Recruiting

A phase III study of the impact of a physical activity program on disease –free survival in patients with high risk stage II or stage III colon cancer: a randomised controlled trial

http://clinicaltrials.gov/show/NCT00819208


COTEZO 

GO 30182A Phase III, open-label, multicenter, three-arm, randomized study to investigate the efficacy and safety of cobimetinib plus atezolizumab and atezolizumab monotherapy vs. regorafenib in patients with previously treated unresectable locally advanced or metastatic colorectal carcinoma

https://clinicaltrials.gov/ct2/show/NCT02788279?term=atezolizumab+and+cobimetinib&rank=5


Doctor 

Doctor Trial Randomised phase 2 trial of pre op Cisplatin, 5FU and Docetaxel +/- radiotherapy based on poor early response to standard chemo for resectable adenocarcinoma of the oesophagus and or OG junction

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=308313


Gilead - Recruiting

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-5745 Combined with mFOLFOX6 as First Line Treatment in Patients with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

https://clinicaltrials.gov/ct2/show/NCT02545504

Back to Top

Sydney Adventist Hospital Clinical Specialties and Services